Nash MM - Search Results

1

Twenty four-hour ambulatory blood pressure profiles 12 months post living kidney donation.

Ramesh Prasad GV, Lipszyc D, Sarker S, Huang M, Nash MM, Rapi L. Ramesh Prasad GV, et al. Among authors: nash mm. Transpl Int. 2010 Aug;23(8):771-6. doi: 10.1111/j.1432-2277.2009.01040.x. Epub 2010 Jan 6. Transpl Int. 2010. PMID: 20059751 Free article.

2

Seasonal variation in outpatient blood pressure in stable renal transplant recipients.

Prasad GV, Nash MM, Zaltzman JS. Prasad GV, et al. Among authors: nash mm. Transplantation. 2001 Dec 15;72(11):1792-4. doi: 10.1097/00007890-200112150-00014. Transplantation. 2001. PMID: 11740390

3

Blood pressure reduction with HMG-CoA reductase inhibitors in renal transplant recipients.

Prasad GV, Ahmed A, Nash MM, Zaltzman JS. Prasad GV, et al. Among authors: nash mm. Kidney Int. 2003 Jan;63(1):360-4. doi: 10.1046/j.1523-1755.2003.00742.x. Kidney Int. 2003. PMID: 12472804 Free article.

4

A prospective study of the physician effect on blood pressure in renal-transplant recipients.

Prasad GV, Nash MM, Zaltzman JS. Prasad GV, et al. Among authors: nash mm. Nephrol Dial Transplant. 2003 May;18(5):996-1000. doi: 10.1093/ndt/gfg038. Nephrol Dial Transplant. 2003. PMID: 12686677

5

The benefits of renin-angiotensin blockade in renal transplant recipients with biopsy-proven allograft nephropathy.

Zaltzman JS, Nash M, Chiu R, Prasad R. Zaltzman JS, et al. Nephrol Dial Transplant. 2004 Apr;19(4):940-4. doi: 10.1093/ndt/gfg593. Nephrol Dial Transplant. 2004. PMID: 15031353 Clinical Trial.

6

Reduced incidence of new-onset diabetes mellitus after renal transplantation with 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors (statins).

Prasad GV, Kim SJ, Huang M, Nash MM, Zaltzman JS, Fenton SS, Cattran DC, Cole EH, Cardella CJ. Prasad GV, et al. Among authors: nash mm. Am J Transplant. 2004 Nov;4(11):1897-903. doi: 10.1046/j.1600-6143.2004.00598.x. Am J Transplant. 2004. PMID: 15476492 Free article.

7

Diltiazem use in tacrolimus-treated renal transplant recipients.

Kothari J, Nash M, Zaltzman J, Ramesh Prasad GV. Kothari J, et al. J Clin Pharm Ther. 2004 Oct;29(5):425-30. doi: 10.1111/j.1365-2710.2004.00578.x. J Clin Pharm Ther. 2004. PMID: 15482385

8

Role of dietary salt intake in posttransplant hypertension with tacrolimus-based immunosuppression.

Prasad GV, Huang M, Nash MM, Zaltzman JS. Prasad GV, et al. Among authors: nash mm. Transplant Proc. 2005 May;37(4):1896-7. doi: 10.1016/j.transproceed.2005.04.002. Transplant Proc. 2005. PMID: 15919496

9

The role of dietary cations in the blood pressure of renal transplant recipients.

Ramesh Prasad GV, Huang M, Nash MM, Zaltzman JS. Ramesh Prasad GV, et al. Among authors: nash mm. Clin Transplant. 2006 Jan-Feb;20(1):37-42. doi: 10.1111/j.1399-0012.2005.00437.x. Clin Transplant. 2006. PMID: 16556151

10

A comparison of the effects of C2-cyclosporine and C0-tacrolimus on renal function and cardiovascular risk factors in kidney transplant recipients.

Kim SJ, Prasad GV, Huang M, Nash MM, Famure O, Park J, Thenganatt MA, Chowdhury N, Cole EH, Fenton SS, Cattran DC, Zaltzman JS, Cardella CJ. Kim SJ, et al. Among authors: nash mm. Transplantation. 2006 Oct 15;82(7):924-30. doi: 10.1097/01.tp.0000239313.83735.33. Transplantation. 2006. PMID: 17038908

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters